MiNK Therapeutics, Inc. (INKT) Tops Q2 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Why Goldman Sachs expects Fed to skip October rate hike
| (NASDAQ: INKT) | Delayed: 10.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.71 | 52 Week High | $ | |||
| Open | $10.71 | 52 Week Low | $ | |||
| Day High | $10.71 | P/E | N/A | |||
| Day Low | $10.71 | EPS | $ | |||
| Volume | 346 | |||||
